Grifols is a Spanish company headquartered in Barcelona and founded in 1909 by Josep Antoni Grifols i Roig, listed on the Bolsa de Madrid with the founding family still significant shareholders.
Grifols is the world's third-largest maker of plasma-derived medicines, with most of its plasma-collection centres in the United States, and its output is critical infrastructure for global plasma supply when shortages occur.